Skip to main content
. 2021 Oct 14;21:1103. doi: 10.1186/s12885-021-08483-3

Fig. 2.

Fig. 2

Comparison of tumor recurrence-free survival between the 2 groups. Kaplan-Meier curve of tumor recurrence-free survival based on preoperative HBV DNA levels. The median tumor recurrence-free survival was 30.1 months in group 1 and 17.6 months in group 2 (P < 0.01) (log-rank P = 0.015)